NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Stem Pharm

Stem Pharm

Private
Madison, WisconsinHealthcare & Life Scienceshttps://www.stempharm.com/

Last Round

Grant

Feb 3, 2026

Total Funding Raised

$4.46M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Stem Pharm is a biotechnology company that has developed a drug discovery platform intended to focus on diseases related to inflammation in the brain.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Advanced Materials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts, Hardware Sales

AI Layer

Non-AI

Keywords

human neural organoidsbrains-in-a-dishdrug discovery platformneurological drug discoveryorganoid modelsanimal testing alternativeneuroinflammation modelscontract research organizationdisease modelingpreclinical models3D cell culturephenotypic screeningneurotoxicity assessmentsynthetic biomaterialshydrogels

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Stem Pharm Comparables

Compare Stem Pharm with similar companies based on industry and business-model similarity.

Stem Pharm comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Stem Pharm Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 3, 2026
GrantSep 1, 2023
GrantAug 10, 2023
AcceleratorDec 20, 2022
GrantMar 17, 2021
Grant
Aug 12, 2020

Key People

Founding team and executive leadership

Steven Visuri

CEO

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 17, 2026

    Monthly visitors grew 68% MoM, reaching 1.4K.

  • Feb 3, 2026

    Received grant funding from BioForward Wisconsin and Forward BIOLABS.

Stem Pharm Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Stem Pharm Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Stem Pharm's valuation, stock price, and market status.

Firmographic Details

HeadquartersMadison, Wisconsin
Employee Range8
Year Founded2015
Last FundingFeb 3, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.